BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 25700239)

  • 41. Total neurological recovery after surgical decompression and treatment with denosumab of large unresectable spinal giant cell tumour expanding to mediastinum.
    Anusitviwat C; Ruangchainikom M; Korwutthikulrangsri E; Sutipornpalangkul W
    BMJ Case Rep; 2022 May; 15(5):. PubMed ID: 35550320
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A nonrandomized controlled study of sacral giant cell tumors with preoperative treatment of denosumab.
    Yang Y; Li Y; Liu W; Xu H; Niu X
    Medicine (Baltimore); 2018 Nov; 97(46):e13139. PubMed ID: 30431583
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Giant cell tumor: rapid recurrence after cessation of long-term denosumab therapy.
    Matcuk GR; Patel DB; Schein AJ; White EA; Menendez LR
    Skeletal Radiol; 2015 Jul; 44(7):1027-31. PubMed ID: 25712768
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Surgical management of spinal osteoblastomas.
    Versteeg AL; Dea N; Boriani S; Varga PP; Luzzati A; Fehlings MG; Bilsky MH; Rhines LD; Reynolds JJ; Dekutoski MB; Gokaslan ZL; Germscheid NM; Fisher CG
    J Neurosurg Spine; 2017 Sep; 27(3):321-327. PubMed ID: 28686147
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Surgical management of primary and metastatic sarcoma of the mobile spine.
    Rao G; Suki D; Chakrabarti I; Feiz-Erfan I; Mody MG; McCutcheon IE; Gokaslan Z; Patel S; Rhines LD
    J Neurosurg Spine; 2008 Aug; 9(2):120-8. PubMed ID: 18764743
    [TBL] [Abstract][Full Text] [Related]  

  • 46. En bloc resection of primary tumors of the thoracic spine: indications, planning, morbidity.
    Boriani S; Bandiera S; Colangeli S; Ghermandi R; Gasbarrini A
    Neurol Res; 2014 Jun; 36(6):566-76. PubMed ID: 24725289
    [TBL] [Abstract][Full Text] [Related]  

  • 47. En Bloc Resection Versus Intralesional Surgery in the Treatment of Giant Cell Tumor of the Spine.
    Charest-Morin R; Fisher CG; Varga PP; Gokaslan ZL; Rhines LD; Reynolds JJ; Dekutoski MB; Quraishi NA; Bilsky MH; Fehlings MG; Chou D; Germscheid NM; Luzzati A; Boriani S;
    Spine (Phila Pa 1976); 2017 Sep; 42(18):1383-1390. PubMed ID: 28146024
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Giant cell tumor of the thoracic spine causing acute paraplegia-a case report.
    Lucasti C; Patel D; Hawayek B; Maraschiello M; Kowalski J
    J Spine Surg; 2021 Jun; 7(2):208-213. PubMed ID: 34296034
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Giant cell tumour of bone.
    Thomas DM; Skubitz KM
    Curr Opin Oncol; 2009 Jul; 21(4):338-44. PubMed ID: 19444102
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Denosumab treatment for progressive Enneking stage II cervical giant-cell tumor conservatively.
    Tan Y; Zhang S; Zhang J; Huang T; Li X; Zhou X; Zhang J
    Funct Integr Genomics; 2023 Mar; 23(1):76. PubMed ID: 36867323
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Surgical management of cervical spine manifestations of neurofibromatosis Type 1: long-term clinical and radiological follow-up in 22 cases.
    Taleb FS; Guha A; Arnold PM; Fehlings MG; Massicotte EM
    J Neurosurg Spine; 2011 Mar; 14(3):356-66. PubMed ID: 21235302
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Denosumab Therapy Obscures Histological Features of Giant Cell Tumor of Bone.
    Gilani A; Kleinschmidt-DeMasters BK
    J Neuropathol Exp Neurol; 2019 Dec; 78(12):1171-1173. PubMed ID: 31665371
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The outcome of surgical treatment for recurrent giant cell tumor in the appendicular skeleton.
    Wan R; Zhang W; Xu J; Hao P; Yang Y; Shen Y; Ding X; Qiu S
    J Orthop Sci; 2012 Jul; 17(4):464-9. PubMed ID: 22526715
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Surgical downstaging in an open-label phase II trial of denosumab in patients with giant cell tumor of bone.
    Rutkowski P; Ferrari S; Grimer RJ; Stalley PD; Dijkstra SP; Pienkowski A; Vaz G; Wunder JS; Seeger LL; Feng A; Roberts ZJ; Bach BA
    Ann Surg Oncol; 2015 Sep; 22(9):2860-8. PubMed ID: 26033180
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Safety and efficacy of denosumab in the treatment of pulmonary metastatic giant cell tumor of bone.
    Luo Y; Tang F; Wang Y; Zhou Y; Min L; Zhang W; Shi R; Duan H; Tu C
    Cancer Manag Res; 2018; 10():1901-1906. PubMed ID: 30013396
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Denosumab treatment of metastatic giant-cell tumor of bone in a 10-year-old girl.
    Karras NA; Polgreen LE; Ogilvie C; Manivel JC; Skubitz KM; Lipsitz E
    J Clin Oncol; 2013 Apr; 31(12):e200-2. PubMed ID: 23509309
    [No Abstract]   [Full Text] [Related]  

  • 57. Remarkable regression of a giant cell tumor of the cervical spine treated conservatively with denosumab: A case report.
    Nakazawa T; Inoue G; Imura T; Miyagi M; Saito W; Namba T; Shirasawa E; Uchida K; Takahira N; Takaso M
    Int J Surg Case Rep; 2016; 24():22-5. PubMed ID: 27179332
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Denosumab Therapy for Giant-cell Tumor of the Lumbar Spine: A Case Report and Immunohistochemical Examination.
    Yayama T; Mori K; Nakamura A; Mimura T; Imai S
    J Orthop Case Rep; 2020; 10(2):76-79. PubMed ID: 32953662
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Surgical Outcomes in Patients with High Spinal Instability Neoplasm Score Secondary to Spinal Giant Cell Tumors.
    Elder BD; Sankey EW; Goodwin CR; Kosztowski TA; Lo SF; Bydon A; Wolinsky JP; Gokaslan ZL; Witham TF; Sciubba DM
    Global Spine J; 2016 Feb; 6(1):21-8. PubMed ID: 26835198
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Management of spinal giant cell tumors.
    Luksanapruksa P; Buchowski JM; Singhatanadgige W; Rose PC; Bumpass DB
    Spine J; 2016 Feb; 16(2):259-69. PubMed ID: 26523962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.